{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T16:36:04Z","timestamp":1790786164867,"version":"4.1.0"},"reference-count":154,"publisher":"MDPI AG","issue":"22","license":[{"start":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T00:00:00Z","timestamp":1730764800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostics"],"abstract":"<jats:p>Endometrial atypical hyperplasia (EAH) is a premalignant condition with a substantial risk of progression to endometrial cancer (EC), with the endometrioid subtype being the most common. EAH is characterized by abnormal endometrial gland proliferation and cellular atypia, often resulting from prolonged unopposed estrogen exposure. This review aims to explore the clinical significance of EAH, its risk of progression to EC, and the current approaches to management. The risk of EAH progressing to EC ranges from 20 to 50%, influenced by factors such as histopathology and genetic mutations including PTEN and KRAS. Key risk factors include obesity, polycystic ovary syndrome, and postmenopausal status. Abnormal uterine bleeding is a hallmark symptom of EAH and early-stage EC, necessitating diagnostic evaluation through endometrial biopsy and transvaginal ultrasonography. Therapeutic management strategies depend on patient risk and fertility considerations. Hormonal therapy, particularly progestins, is the mainstay for fertility preservation, while hysterectomy is preferred for higher-risk patients. Regular monitoring with biopsies is essential for those undergoing conservative treatment. Recent advancements in the management of EAH and EC have shifted towards incorporation of molecular diagnostics and targeted therapies, enabling better risk stratification and individualized care. Biomarkers and minimally invasive surgical techniques are emerging as promising approaches in improving outcomes for women with EAH. This review underscores the importance of early diagnosis and personalized management in preventing the progression of EAH to EC, highlighting current clinical practices and potential future developments in this field.<\/jats:p>","DOI":"10.3390\/diagnostics14222471","type":"journal-article","created":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T06:30:48Z","timestamp":1730788248000},"page":"2471","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["Endometrial Atypical Hyperplasia and Risk of Endometrial Cancer"],"prefix":"10.3390","volume":"14","author":[{"given":"An-Ju","family":"Chou","sequence":"first","affiliation":[{"name":"Department of Medicine, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Tzu Chi University, New Taipei City 231, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruo-Shi","family":"Bing","sequence":"additional","affiliation":[{"name":"Department of Medicine, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Tzu Chi University, New Taipei City 231, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5105-068X","authenticated-orcid":false,"given":"Dah-Ching","family":"Ding","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Tzu Chi University, Hualien 970, Taiwan"},{"name":"Institute of Medical Sciences, Tzu Chi University, Hualien 970, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,11,5]]},"reference":[{"key":"ref_1","first-page":"1061","article-title":"Endometrial Hyperplasia","volume":"140","author":"Ring","year":"2022","journal-title":"Obstet. Gynecol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s00404-021-06380-5","article-title":"Endometrial Hyperplasia as a Risk Factor of Endometrial Cancer","volume":"306","author":"Nees","year":"2022","journal-title":"Arch. Gynecol. Obstet."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.ejogrb.2022.04.019","article-title":"Reproductive and Pregnancy Outcomes of Fertility-Sparing Treatments for Early-Stage Endometrial Cancer or Atypical Hyperplasia: A Systematic Review and Meta-Analysis","volume":"273","author":"Buca","year":"2022","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Ding, Y., Fan, Y., Li, X., Wang, Y., Wang, J., and Tian, L. (2022). Metabolic Syndrome Is an Independent Risk Factor for Time to Complete Remission of Fertility-Sparing Treatment in Atypical Endometrial Hyperplasia and Early Endometrial Carcinoma Patients. Reprod. Biol. Endocrinol., 20.","DOI":"10.1186\/s12958-022-01006-0"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"300","DOI":"10.5468\/ogs.20294","article-title":"Non-Atypical Endometrial Hyperplasia: Risk Factors for Occult Endometrial Atypia and Malignancy in Patients Managed with Hysterectomy","volume":"64","author":"Hui","year":"2021","journal-title":"Obstet. Gynecol. Sci."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1111\/jog.14474","article-title":"Risk of Occult Atypical Hyperplasia or Cancer in Women with Nonatypical Endometrial Hyperplasia","volume":"46","author":"Lee","year":"2020","journal-title":"J. Obstet. Gynaecol. Res."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Uccella, S., Zorzato, P.C., Dababou, S., Bosco, M., Torella, M., Braga, A., Frigerio, M., Gardella, B., Cianci, S., and Lagan\u00e0, A.S. (2022). Conservative Management of Atypical Endometrial Hyperplasia and Early Endometrial Cancer in Childbearing Age Women. Medicina, 58.","DOI":"10.3390\/medicina58091256"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Contreras, N.-A., Sabadell, J., Verdaguer, P., Juli\u00e0, C., and Fern\u00e1ndez-Montol\u00ed, M.-E. (2022). Fertility-Sparing Approaches in Atypical Endometrial Hyperplasia and Endometrial Cancer Patients: Current Evidence and Future Directions. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23052531"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.1200\/JCO.2012.48.2596","article-title":"Type I and II Endometrial Cancers: Have They Different Risk Factors?","volume":"31","author":"Setiawan","year":"2013","journal-title":"J. Clin. Oncol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.maturitas.2009.02.005","article-title":"Endometrial Hyperplasia and the Risk of Progression to Carcinoma","volume":"63","author":"Lacey","year":"2009","journal-title":"Maturitas"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"(2023). Management of Endometrial Intraepithelial Neoplasia or Atypical Endometrial Hyperplasia: ACOG Clinical Consensus No. 5. Obstet. Gynecol., 142, 735\u2013744.","DOI":"10.1097\/AOG.0000000000005297"},{"key":"ref_12","first-page":"107","article-title":"New Classification System of Endometrial Hyperplasia WHO 2014 and Its Clinical Implications","volume":"16","author":"Sobczuk","year":"2017","journal-title":"Prz. Menopauzalny"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1097\/PAS.0000000000001705","article-title":"Atypical Endometrial Hyperplasia, Low-Grade: \u201cMuch ADO about Nothing\u201d","volume":"45","author":"Espinosa","year":"2021","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1053\/j.semdp.2021.12.001","article-title":"Histopathologic Diagnosis of Endometrial Precancers: Updates and Future Directions","volume":"39","author":"Chen","year":"2022","journal-title":"Semin. Diagn. Pathol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/path.5566","article-title":"Genome-Wide Mutation Analysis in Precancerous Lesions of Endometrial Carcinoma","volume":"253","author":"Li","year":"2021","journal-title":"J. Pathol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1007\/s10552-015-0666-5","article-title":"PTEN Expression in Benign Human Endometrial Tissue and Cancer in Relation to Endometrial Cancer Risk Factors","volume":"26","author":"Yang","year":"2015","journal-title":"Cancer Causes Control"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/modpathol.2011.208","article-title":"Clinical Assessment of PTEN Loss in Endometrial Carcinoma: Immunohistochemistry Outperforms Gene Sequencing","volume":"25","author":"Djordjevic","year":"2012","journal-title":"Mod. Pathol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"533","DOI":"10.21873\/anticanres.13145","article-title":"The Role of KRAS in Endometrial Cancer: A Mini-Review","volume":"39","author":"Sideris","year":"2019","journal-title":"Anticancer Res."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.21037\/tcr-20-2969","article-title":"KRAS, YWHAE, SP1 and MSRA as Biomarkers in Endometrial Cancer","volume":"10","author":"Yang","year":"2021","journal-title":"Transl. Cancer Res."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"201","DOI":"10.31557\/apjcb.2024.9.2.201-208","article-title":"Biomarker Panel for Early Detection in Uterine Cancer: A Review","volume":"9","author":"Priya","year":"2024","journal-title":"Asian Pac. J. Canc. Biol."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Kavun, A., Veselovsky, E., Lebedeva, A., Belova, E., Kuznetsova, O., Yakushina, V., Grigoreva, T., Mileyko, V., Fedyanin, M., and Ivanov, M. (2023). Microsatellite Instability: A Review of Molecular Epidemiology and Implications for Immune Checkpoint Inhibitor Therapy. Cancers, 15.","DOI":"10.3390\/cancers15082288"},{"key":"ref_22","first-page":"70","article-title":"Endometrial Cancer and Microsatellite Instability Status","volume":"10","author":"Kanopiene","year":"2015","journal-title":"Open Med."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1002\/cncr.32058","article-title":"Microsatellite Instability in Endometrial Cancer: New Purpose for an Old Test","volume":"125","author":"Kurnit","year":"2019","journal-title":"Cancer"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s12672-019-0358-9","article-title":"Estrogen Signaling in Endometrial Cancer: A Key Oncogenic Pathway with Several Open Questions","volume":"10","author":"Rodriguez","year":"2019","journal-title":"Horm. Cancer"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jsbmb.2013.05.001","article-title":"Menopausal Hormone Therapy and Risk of Endometrial Cancer","volume":"142","author":"Brinton","year":"2014","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1210\/er.2012-1043","article-title":"Progesterone Action in Endometrial Cancer, Endometriosis, Uterine Fibroids, and Breast Cancer","volume":"34","author":"Kim","year":"2013","journal-title":"Endocr. Rev."},{"key":"ref_27","first-page":"e37266","article-title":"Risk of Gynecological Cancers in Women with Polycystic Ovary Syndrome and the Pathophysiology of Association","volume":"15","author":"Shetty","year":"2023","journal-title":"Cureus"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"e12608","DOI":"10.1097\/MD.0000000000012608","article-title":"Association between Polycystic Ovarian Syndrome and Endometrial, Ovarian, and Breast Cancer","volume":"97","author":"Ding","year":"2018","journal-title":"Medicine"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1200\/JCO.2009.24.1315","article-title":"Absolute Risk of Endometrial Carcinoma during 20-Year Follow-up among Women with Endometrial Hyperplasia","volume":"28","author":"Lacey","year":"2010","journal-title":"J. Clin. Oncol."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Giannella, L., Grelloni, C., Bernardi, M., Cicoli, C., Lavezzo, F., Sartini, G., Natalini, L., Bordini, M., Petrini, M., and Petrucci, J. (2024). Atypical Endometrial Hyperplasia and Concurrent Cancer: A Comprehensive Overview on a Challenging Clinical Condition. Cancers, 16.","DOI":"10.3390\/cancers16050914"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/1097-0142(19850715)56:2<403::AID-CNCR2820560233>3.0.CO;2-X","article-title":"The Behavior of Endometrial Hyperplasia. A Long-Term Study of \u201cUntreated\u201d Hyperplasia in 170 Patients","volume":"56","author":"Kurman","year":"1985","journal-title":"Cancer"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Doherty, M.T., Sanni, O.B., Coleman, H.G., Cardwell, C.R., McCluggage, W.G., Quinn, D., Wylie, J., and McMenamin, \u00da.C. (2020). Concurrent and Future Risk of Endometrial Cancer in Women with Endometrial Hyperplasia: A Systematic Review and Meta-Analysis. PLoS ONE, 15.","DOI":"10.1371\/journal.pone.0232231"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1080\/01443610802355817","article-title":"Endometrial Atypical Hyperplasia and Subsequent Diagnosis of Endometrial Cancer: A Retrospective Audit and Literature Review","volume":"28","author":"Pennant","year":"2008","journal-title":"J. Obstet. Gynaecol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/sj.bjc.6604102","article-title":"Endometrial Carcinoma Risk among Women Diagnosed with Endometrial Hyperplasia: The 34-Year Experience in a Large Health Plan","volume":"98","author":"Lacey","year":"2008","journal-title":"Br. J. Cancer"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1097\/AOG.0000000000001566","article-title":"Atypical Endometrial Polyps and Concurrent Endometrial Cancer","volume":"128","author":"Steenbergen","year":"2016","journal-title":"Obstet. Gynecol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1007\/s00404-019-05103-1","article-title":"Endometrial Hyperplasia and Progression to Cancer: Which Classification System Stratifies the Risk Better? A Systematic Review and Meta-Analysis","volume":"299","author":"Raffone","year":"2019","journal-title":"Arch. Gynecol. Obstet."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/apm.12945","article-title":"Complexity of Glandular Architecture Should Be Reconsidered in the Classification and Management of Endometrial Hyperplasia","volume":"127","author":"Travaglino","year":"2019","journal-title":"APMIS"},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Jeong, J.Y., Hwang, S.O., Lee, B., Kim, K., Kim, Y.B., Park, S.H., and Choi, H.Y. (2020). Risk Factors of Progression to Endometrial Cancer in Women with Endometrial Hyperplasia: A Retrospective Cohort Study. PLoS ONE, 15.","DOI":"10.1371\/journal.pone.0243064"},{"key":"ref_39","first-page":"CD000402","article-title":"Hormone Therapy in Postmenopausal Women and Risk of Endometrial Hyperplasia","volume":"3","author":"Furness","year":"2012","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1093\/aje\/kwq300","article-title":"Menopausal Hormone Therapy and Risk of Endometrial Carcinoma among Postmenopausal Women in the European Prospective Investigation Into Cancer and Nutrition","volume":"172","author":"Allen","year":"2010","journal-title":"Am. J. Epidemiol."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Tempfer, C.B., Hilal, Z., Kern, P., Juhasz-Boess, I., and Rezniczek, G.A. (2020). Menopausal Hormone Therapy and Risk of Endometrial Cancer: A Systematic Review. Cancers, 12.","DOI":"10.3390\/cancers12082195"},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Hetem\u00e4ki, N., Mikkola, T.S., Tikkanen, M.J., Wang, F., H\u00e4m\u00e4l\u00e4inen, E., Turpeinen, U., Haanp\u00e4\u00e4, M., Vihma, V., and Savolainen-Peltonen, H. (2021). Adipose Tissue Estrogen Production and Metabolism in Premenopausal Women. J. Steroid Biochem. Mol. Biol., 209.","DOI":"10.1016\/j.jsbmb.2021.105849"},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Kury\u0142owicz, A. (2023). Estrogens in Adipose Tissue Physiology and Obesity-Related Dysfunction. Biomedicines, 11.","DOI":"10.3390\/biomedicines11030690"},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Yu, K., Huang, Z.-Y., Xu, X.-L., Li, J., Fu, X.-W., and Deng, S.-L. (2022). Estrogen Receptor Function: Impact on the Human Endometrium. Front. Endocrinol., 13.","DOI":"10.3389\/fendo.2022.827724"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"598.e1","DOI":"10.1016\/j.ajog.2016.06.006","article-title":"Body Mass Index Trumps Age in Decision for Endometrial Biopsy: Cohort Study of Symptomatic Premenopausal Women","volume":"215","author":"Wise","year":"2016","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"e11010","DOI":"10.1016\/j.heliyon.2022.e11010","article-title":"An Update of Polycystic Ovary Syndrome: Causes and Therapeutics Options","volume":"8","author":"Matani","year":"2022","journal-title":"Heliyon"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"4444","DOI":"10.21037\/tcr-19-1956","article-title":"Selective Estrogen Receptor Modulators in the Prevention of Breast Cancer in Premenopausal Women: A Review","volume":"9","author":"Topete","year":"2020","journal-title":"Transl. Cancer Res."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"e2243951","DOI":"10.1001\/jamanetworkopen.2022.43951","article-title":"Risk of Endometrial Polyps, Hyperplasia, Carcinoma, and Uterine Cancer after Tamoxifen Treatment in Premenopausal Women with Breast Cancer","volume":"5","author":"Ryu","year":"2022","journal-title":"JAMA Netw. Open"},{"key":"ref_49","first-page":"e20030","article-title":"Endometrial Surveillance in Tamoxifen and Letrozole Treated Breast Cancer Patients","volume":"13","author":"AlZaabi","year":"2021","journal-title":"Cureus"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1038\/bjc.2015.24","article-title":"Infertility and Incident Endometrial Cancer Risk: A Pooled Analysis from the Epidemiology of Endometrial Cancer Consortium (E2C2)","volume":"112","author":"Yang","year":"2015","journal-title":"Br. J. Cancer"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1097\/EDE.0b013e3182263018","article-title":"Pregnancy History and Risk of Endometrial Cancer","volume":"22","author":"Pocobelli","year":"2011","journal-title":"Epidemiology"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"e2332296","DOI":"10.1001\/jamanetworkopen.2023.32296","article-title":"Reproductive Factors and Endometrial Cancer Risk Among Women","volume":"6","author":"Katagiri","year":"2023","journal-title":"JAMA Netw. Open"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s10689-018-00117-1","article-title":"Recent Advances in Lynch Syndrome","volume":"18","author":"Biller","year":"2019","journal-title":"Fam. Cancer"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1056\/NEJMcp1714533","article-title":"Lynch Syndrome-Associated Colorectal Cancer","volume":"379","author":"Sinicrope","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/ijc.33763","article-title":"Endometrial Cancer in Lynch Syndrome","volume":"150","author":"Zhao","year":"2022","journal-title":"Int. J. Cancer"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1056\/NEJMra1514010","article-title":"Endometrial Cancer","volume":"383","author":"Lu","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1097\/AOG.0b013e318270444f","article-title":"Management of Reproductive Health in Cowden Syndrome Complicated by Endometrial Polyps and Breast Cancer","volume":"121","author":"Kalin","year":"2013","journal-title":"Obstet. Gynecol."},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Clontz, A.D., Gan, E., Hursting, S.D., and Bae-Jump, V.L. (2024). Effects of Weight Loss on Key Obesity-Related Biomarkers Linked to the Risk of Endometrial Cancer: A Systematic Review and Meta-Analysis. Cancers, 16.","DOI":"10.3390\/cancers16122197"},{"key":"ref_59","first-page":"697521","article-title":"The Role of Chronic Inflammation in Obesity-Associated Cancers","volume":"2013","year":"2013","journal-title":"ISRN Oncol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"3611","DOI":"10.2147\/DMSO.S275898","article-title":"Obesity, Insulin Resistance, and Type 2 Diabetes: Associations and Therapeutic Implications","volume":"13","author":"Wondmkun","year":"2020","journal-title":"Diabetes Metab. Syndr. Obes."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1002\/1878-0261.12772","article-title":"Physical Activity, Obesity and Sedentary Behavior in Cancer Etiology: Epidemiologic Evidence and Biologic Mechanisms","volume":"15","author":"Friedenreich","year":"2021","journal-title":"Mol. Oncol."},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Spanoudaki, M., Giaginis, C., Karafyllaki, D., Papadopoulos, K., Solovos, E., Antasouras, G., Sfikas, G., Papadopoulos, A.N., and Papadopoulou, S.K. (2023). Exercise as a Promising Agent against Cancer: Evaluating Its Anti-Cancer Molecular Mechanisms. Cancers, 15.","DOI":"10.3390\/cancers15215135"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1093\/bmb\/ldab019","article-title":"Why Exercise Has a Crucial Role in Cancer Prevention, Risk Reduction and Improved Outcomes","volume":"139","author":"Thomas","year":"2021","journal-title":"Br. Med. Bull."},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Njoku, K., Agnew, H.J., and Crosbie, E.J. (2022). Impact of Type 2 Diabetes Mellitus on Endometrial Cancer Survival: A Prospective Database Analysis. Front. Oncol., 12.","DOI":"10.3389\/fonc.2022.899262"},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Sidorkiewicz, I., J\u00f3\u017awik, M., Niemira, M., and Kr\u0119towski, A. (2020). Insulin Resistance and Endometrial Cancer: Emerging Role for microRNA. Cancers, 12.","DOI":"10.3390\/cancers12092559"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"e30299","DOI":"10.1097\/MD.0000000000030299","article-title":"Diabetes Mellitus and Endometrial Carcinoma: Risk Factors and Etiological Links","volume":"101","author":"Wang","year":"2022","journal-title":"Medicine"},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Stanciu, S., Rusu, E., Miricescu, D., Radu, A.C., Axinia, B., Vrabie, A.M., Ionescu, R., Jinga, M., and Sirbu, C.A. (2023). Links between Metabolic Syndrome and Hypertension: The Relationship with the Current Antidiabetic Drugs. Metabolites, 13.","DOI":"10.3390\/metabo13010087"},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"El Meouchy, P., Wahoud, M., Allam, S., Chedid, R., Karam, W., and Karam, S. (2022). Hypertension Related to Obesity: Pathogenesis, Characteristics and Factors for Control. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms232012305"},{"key":"ref_69","first-page":"788","article-title":"Data from Hypertension and Risk of Endometrial Cancer: A Pooled Analysis in the Epidemiology of Endometrial Cancer Consortium (E2C2)","volume":"33","author":"Habeshian","year":"2024","journal-title":"Am. Assoc. Cancer Res."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"e753","DOI":"10.1097\/MD.0000000000000753","article-title":"Hypertension and Subsequent Genitourinary and Gynecologic Cancers Risk: A Population-Based Cohort Study","volume":"94","author":"Sun","year":"2015","journal-title":"Medicine"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"7767","DOI":"10.21037\/tcr-20-2092","article-title":"Hysteroscopy in the Management of Endometrial Hyperplasia and Cancer in Reproductive Aged Women: New Developments and Current Perspectives","volume":"9","author":"Vitale","year":"2020","journal-title":"Transl. Cancer Res."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.bpobgyn.2015.11.012","article-title":"Abnormal Uterine Bleeding","volume":"34","author":"Whitaker","year":"2016","journal-title":"Best Pract. Res. Clin. Obstet. Gynaecol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.ejogrb.2016.10.001","article-title":"Polycystic Ovary Syndrome and Endometrial Hyperplasia: An Overview of the Role of Bariatric Surgery in Female Fertility","volume":"207","author":"Charalampakis","year":"2016","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.12998\/wjcc.v10.i7.2159","article-title":"Pathological Pattern of Endometrial Abnormalities in Postmenopausal Women with Bleeding or Thickened Endometrium","volume":"10","author":"Xue","year":"2022","journal-title":"World J. Clin. Cases"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1111\/aogs.13022","article-title":"Long-Term Risk of Endometrial Cancer Following Postmenopausal Bleeding and Reassuring Endometrial Biopsy","volume":"95","author":"Visser","year":"2016","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"4289931","DOI":"10.1155\/2021\/4289931","article-title":"The Value of Vaginal Microbiome in Patients with Endometrial Hyperplasia","volume":"2021","author":"Zhang","year":"2021","journal-title":"J. Healthc. Eng."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/CM9.0000000000001109","article-title":"Microscale Endometrial Sampling Biopsy in Detecting Endometrial Cancer and Atypical Hyperplasia in a Population of 1551 Women: A Comparative Study with Hysteroscopic Endometrial Biopsy","volume":"134","author":"Zhang","year":"2020","journal-title":"Chin. Med. J."},{"key":"ref_78","first-page":"463","article-title":"Endometrial Sampling for Endometrial Cancer: Still the Gold Standard?","volume":"2","year":"2019","journal-title":"Am. J. Biomed. Sci. Res."},{"key":"ref_79","first-page":"75","article-title":"Study of the Efficacy of Pipelle Biopsy Technique to Diagnose Endometrial Diseases in Abnormal Uterine Bleeding","volume":"10","author":"Ilavarasi","year":"2019","journal-title":"J. Midlife. Health"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"e16522","DOI":"10.1200\/jco.2013.31.15_suppl.e16522","article-title":"Novel Approach to Outpatient Endometrial Biopsy to Detect Endometrial Cancer","volume":"31","author":"Howard","year":"2013","journal-title":"J. Clin. Oncol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"104","DOI":"10.5505\/kjms.2020.80148","article-title":"How Compatible Are Hysterectomy Pathology Results with Endometrial Biopsy in Abnormal Uterine Bleeding Women?","volume":"10","author":"Turan","year":"2020","journal-title":"Kafkas J. Med. Sci."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"7716","DOI":"10.21037\/tcr.2020.04.20","article-title":"Current Role of Pipelle Endometrial Sampling in Early Diagnosis of Endometrial Cancer","volume":"9","author":"Terzic","year":"2020","journal-title":"Transl. Cancer Res."},{"key":"ref_83","doi-asserted-by":"crossref","unstructured":"Liu, Y., Zhou, Q., Peng, B., Jiang, J., Fang, L., Weng, W., Wang, W., Wang, S., and Zhu, X. (2022). Automatic Measurement of Endometrial Thickness from Transvaginal Ultrasound Images. Front. Bioeng. Biotechnol., 10.","DOI":"10.3389\/fbioe.2022.853845"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"353","DOI":"10.4103\/0300-1652.170390","article-title":"Role of Transvaginal Ultrasonography in Diagnosing Endometrial Hyperplasia in Pre- and Post-Menopause Women","volume":"56","author":"Shokouhi","year":"2015","journal-title":"Niger. Med. J."},{"key":"ref_85","first-page":"155836","article-title":"Diagnosis of Endometrial Hyperplasia in Routine Gynecological Practice","volume":"1","author":"Poliakova","year":"2019","journal-title":"Zaporozhye Med. J."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.diii.2015.11.007","article-title":"Differentiation between Endometrial Carcinoma and Atypical Endometrial Hyperplasia with Transvaginal Sonographic Elastography","volume":"97","author":"Metin","year":"2016","journal-title":"Diagn. Interv. Imaging"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"445","DOI":"10.5468\/ogs.2019.62.6.445","article-title":"Endometrial Thickness Cut-off Value by Transvaginal Ultrasonography for Screening of Endometrial Pathology in Premenopausal and Postmenopausal Women","volume":"62","author":"Park","year":"2019","journal-title":"Obstet. Gynecol. Sci."},{"key":"ref_88","first-page":"249","article-title":"Clinical Value of Transvaginal Ultrasonography in Comparison to Hysteroscopy with Histopathologic Examination in Diagnosing Endometrial Abnormalities","volume":"58","author":"Kuna","year":"2019","journal-title":"Acta Clin. Croat."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"88","DOI":"10.4103\/GMIT.GMIT_15_18","article-title":"Hysteroscopy as a Tool for Identification of Uterine Endocervical Lesion","volume":"7","author":"Valino","year":"2018","journal-title":"Gynecol. Minim. Invasive Ther."},{"key":"ref_90","first-page":"412","article-title":"The Value of Hysteroscopic Biopsy in the Diagnosis of Endometrial Polyps","volume":"12","author":"Elias","year":"2016","journal-title":"Women\u2019s Health"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.gmit.2016.08.006","article-title":"Endometrial Adenomyoma Polyp Caused Postmenopausal Bleeding Mimicking Uterine Malignancy","volume":"6","author":"Huang","year":"2017","journal-title":"Gynecol. Minim. Invasive Ther."},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"De Franciscis, P., Riemma, G., Schiattarella, A., Cobellis, L., Guadagno, M., Vitale, S.G., Mosca, L., Cianci, A., and Colacurci, N. (2019). Concordance between the Hysteroscopic Diagnosis of Endometrial Hyperplasia and Histopathological Examination. Diagnostics, 9.","DOI":"10.3390\/diagnostics9040142"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"149","DOI":"10.4172\/2161-038X.1000149","article-title":"Evaluation of Intrauterine Pathology: Efficacy of Diagnostic Hysteroscopy in Comparison to Histopathological Examination","volume":"4","author":"Elbareg","year":"2015","journal-title":"Reprod. Syst. Sex. Disord."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"8","DOI":"10.22514\/ejgo.2024.022","article-title":"Hysteroscopic-View of Endometrial Atypical Hyperplasia. A Helpful Diagnostic Tool in the Care and Treatment Process?","volume":"45","author":"Garuti","year":"2024","journal-title":"Eur. J. Gynaecol. Oncol."},{"key":"ref_95","first-page":"206","article-title":"Diagnostic Accuracy of Hysteroscopic Scoring System in Predicting Endometrial Malignancy and Atypical Endometrial Hyperplasia","volume":"12","author":"Harika","year":"2021","journal-title":"J. Midlife. Health"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.jmig.2016.02.017","article-title":"A New Hysteroscopic Risk Scoring System for Diagnosing Endometrial Hyperplasia and Adenocarcinoma","volume":"23","author":"Ianieri","year":"2016","journal-title":"J. Minim. Invasive Gynecol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"103","DOI":"10.52054\/FVVO.14.2.023","article-title":"Endometrial Biopsy under Direct Hysteroscopic Visualisation versus Blind Endometrial Sampling for the Diagnosis of Endometrial Hyperplasia and Cancer: Systematic Review and Meta-Analysis","volume":"14","author":"Saccone","year":"2022","journal-title":"Facts Views Vis. ObGyn"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/modpathol.3880053","article-title":"Problems in the Differential Diagnosis of Endometrial Hyperplasia and Carcinoma","volume":"13","author":"Silverberg","year":"2000","journal-title":"Mod. Pathol."},{"key":"ref_99","first-page":"232","article-title":"New Concepts for an Old Problem: The Diagnosis of Endometrial Hyperplasia","volume":"23","author":"Sanderson","year":"2017","journal-title":"Hum. Reprod. Update"},{"key":"ref_100","doi-asserted-by":"crossref","unstructured":"Niu, S., Molberg, K., Castrillon, D.H., Lucas, E., and Chen, H. (2024). Biomarkers in the Diagnosis of Endometrial Precancers. Molecular Characteristics, Candidate Immunohistochemical Markers, and Promising Results of Three-Marker Panel: Current Status and Future Directions. Cancers, 16.","DOI":"10.3390\/cancers16061159"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"7697","DOI":"10.21037\/tcr-20-2074","article-title":"Impact of Endometrial Sampling Technique and Biopsy Volume on the Diagnostic Accuracy of Endometrial Cancer","volume":"9","author":"Ferrari","year":"2020","journal-title":"Transl. Cancer Res."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"141","DOI":"10.3892\/mco.2020.2053","article-title":"Usefulness of Biopsy by Office Hysteroscopy for Endometrial Cancer: A Case Report","volume":"13","author":"Sone","year":"2020","journal-title":"Mol. Clin. Oncol."},{"key":"ref_103","first-page":"e23135","article-title":"Assessing Tumor Size by MRI and Pathology in Type I Endometrial Carcinoma to Predict Lymph Node Metastasis","volume":"14","author":"Ali","year":"2022","journal-title":"Cureus"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"S125","DOI":"10.33549\/physiolres.935030","article-title":"PTEN Mutations as Predictive Marker for the High-Grade Endometrial Cancer Development in Slovak Women","volume":"71","author":"Gergely","year":"2022","journal-title":"Physiol. Res."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1097\/AOG.0000000000004163","article-title":"Fertility-Sparing Treatment for Early-Stage Cervical, Ovarian, and Endometrial Malignancies","volume":"136","author":"Nitecki","year":"2020","journal-title":"Obstet. Gynecol."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.ajog.2015.03.037","article-title":"Levonorgestrel-Releasing Intrauterine System vs Oral Progestins for Non-Atypical Endometrial Hyperplasia: A Systematic Review and Metaanalysis of Randomized Trials","volume":"213","author":"Ghayaty","year":"2015","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_107","doi-asserted-by":"crossref","unstructured":"Cui, J., Zhao, Y.-C., She, L.-Z., and Wang, T.-J. (2024). Comparative Effects of Progestin-Based Combination Therapy for Endometrial Cancer or Atypical Endometrial Hyperplasia: A Systematic Review and Network Meta-Analysis. Front. Oncol., 14.","DOI":"10.3389\/fonc.2024.1391546"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"e8","DOI":"10.3802\/jgo.2016.27.e8","article-title":"Therapeutic Options for Management of Endometrial Hyperplasia","volume":"27","author":"Chandra","year":"2016","journal-title":"J. Gynecol. Oncol."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"108391","DOI":"10.1016\/j.ejso.2024.108391","article-title":"Group for Chinese Guidelines on The Management of Endometrial Hyperplasia Chinese Guidelines on the Management of Endometrial Hyperplasia","volume":"50","author":"Li","year":"2024","journal-title":"Eur. J. Surg. Oncol."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1186\/s13063-024-08414-0","article-title":"GnRH-a-Based Fertility-Sparing Treatment of Atypical Endometrial Hyperplasia (AEH) and Early Endometrial Carcinoma (EC) Patients: A Multicenter, Open-Label, Randomized Designed Clinical Trial Protocol","volume":"25","author":"Liu","year":"2024","journal-title":"Trials"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1097\/PGP.0000000000000344","article-title":"Endometrial Thickness as Measured by Transvaginal Ultrasound and the Corresponding Histopathologic Diagnosis in Women with Postmenopausal Bleeding","volume":"36","author":"Patel","year":"2017","journal-title":"Int. J. Gynecol. Pathol."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.ajog.2011.05.042","article-title":"Understanding Obesity and Endometrial Cancer Risk: Opportunities for Prevention","volume":"205","author":"Schmandt","year":"2011","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s10654-015-0030-9","article-title":"An Epidemiological Model for Prediction of Endometrial Cancer Risk in Europe","volume":"31","author":"Dossus","year":"2016","journal-title":"Eur. J. Epidemiol."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1016\/j.gim.2022.05.014","article-title":"Development and Evaluation of Polygenic Risk Scores for Prediction of Endometrial Cancer Risk in European Women","volume":"24","author":"Bafligil","year":"2022","journal-title":"Genet. Med."},{"key":"ref_115","doi-asserted-by":"crossref","unstructured":"Sanderson, P.A., Esnal-Zufiaurre, A., Arends, M.J., Herrington, C.S., Collins, F., Williams, A.R.W., and Saunders, P.T.K. (2022). Improving the Diagnosis of Endometrial Hyperplasia Using Computerized Analysis and Immunohistochemical Biomarkers. Front. Reprod. Health, 4.","DOI":"10.3389\/frph.2022.896170"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/aogs.13513","article-title":"Loss of PTEN Expression as Diagnostic Marker of Endometrial Precancer: A Systematic Review and Meta-Analysis","volume":"98","author":"Raffone","year":"2019","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"ref_117","first-page":"126","article-title":"Immunoreactivity of PTEN in Cyclic Endometrium and Endometrial Hyperplasia","volume":"13","author":"Elyasergy","year":"2016","journal-title":"World J. Med. Sci."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ejogrb.2018.10.025","article-title":"PTEN as a Predictive Marker of Response to Conservative Treatment in Endometrial Hyperplasia and Early Endometrial Cancer. A Systematic Review and Meta-Analysis","volume":"231","author":"Travaglino","year":"2018","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"ref_119","first-page":"4575","article-title":"Expression of p53 and PTEN in Human Primary Endometrial Carcinomas: Clinicopathological and Immunohistochemical Analysis and Study of Their Concomitant Expression","volume":"17","author":"Stavropoulos","year":"2019","journal-title":"Oncol. Lett."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"21","DOI":"10.31557\/apjcb.2022.7.1.21-27","article-title":"Diagnostic and Prognostic Values of PTEN Expression in Functional and Pathological Endometrial Biopsies","volume":"7","author":"Allithy","year":"2022","journal-title":"Asian Pac. J. Canc. Biol."},{"key":"ref_121","first-page":"e60125","article-title":"P53 Gene as a Promising Biomarker and Potential Target for the Early Diagnosis of Reproductive Cancers","volume":"16","author":"Aswathi","year":"2024","journal-title":"Cureus"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/PGP.0000000000000243","article-title":"TP53 Mutational Spectrum in Endometrioid and Serous Endometrial Cancers","volume":"35","author":"Schultheis","year":"2016","journal-title":"Int. J. Gynecol. Pathol."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.ccr.2014.01.021","article-title":"Mutant p53 in Cancer: New Functions and Therapeutic Opportunities","volume":"25","author":"Muller","year":"2014","journal-title":"Cancer Cell"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.ygyno.2017.05.014","article-title":"Markers of the p53 Pathway Further Refine Molecular Profiling in High-Risk Endometrial Cancer: A TransPORTEC Initiative","volume":"146","author":"Edmondson","year":"2017","journal-title":"Gynecol. Oncol."},{"key":"ref_125","first-page":"14","article-title":"Selected Immunohistochemical Prognostic Factors In Endometrial Hyperplasia versus Carcinoma","volume":"11","author":"Zidan","year":"2015","journal-title":"J. Am. Sci."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"561","DOI":"10.21088\/ijfmp.0974.3383.13420.15","article-title":"A Comparative Study of Expression of PTEN and p53 in Endometrial Hyperplasia and Carcinoma in a Tertiary Care Hospital","volume":"13","author":"Vineetha","year":"2020","journal-title":"Indian J. Forensic Med. Pathol."},{"key":"ref_127","first-page":"563","article-title":"Study of Prognostic and Diagnostic Significance of P53 and PTEN Mutation in Proliferative Lesions of Endometrium","volume":"3","author":"Ray","year":"2020","journal-title":"J. Curr. Med. Res. Opin."},{"key":"ref_128","doi-asserted-by":"crossref","unstructured":"Mendiola, M., Heredia-Soto, V., Ruz-Caracuel, I., Baillo, A., Ramon-Patino, J.L., Escudero, F.J., Miguel, M., Pelaez-Garcia, A., Hernandez, A., and Feliu, J. (2023). Comparison of Methods for Testing Mismatch Repair Status in Endometrial Cancer. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms241914468"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"5160","DOI":"10.12998\/wjcc.v11.i21.5160","article-title":"Neuroendocrine Carcinoma of the Endometrium Concomitant with Lynch Syndrome: A Case Report","volume":"11","author":"Siu","year":"2023","journal-title":"World J. Clin. Cases"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"14","DOI":"10.31088\/CEM2023.12.4.14-22","article-title":"Endometrial Hyperplasia and Microsatellite Instability: Possibilities for Predicting Tumor Transformation of the Endometrium","volume":"12","author":"Kazachkov","year":"2023","journal-title":"Clin. Exp. Morphol."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1038\/s41379-019-0298-5","article-title":"Quantitative next-Generation Sequencing-Based Analysis Indicates Progressive Accumulation of Microsatellite Instability between Atypical Hyperplasia\/endometrial Intraepithelial Neoplasia and Paired Endometrioid Endometrial Carcinoma","volume":"32","author":"Chapel","year":"2019","journal-title":"Mod. Pathol."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1006\/gyno.2002.6724","article-title":"Microsatellite Instability, MLH1 Promoter Methylation, and Loss of Mismatch Repair in Endometrial Cancer and Concomitant Atypical Hyperplasia","volume":"86","author":"Horowitz","year":"2002","journal-title":"Gynecol. Oncol."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/01.pgp.0000101085.35393.4a","article-title":"Molecular Analysis of Endometrial Hyperplasia in HNPCC-Suspicious Patients May Predict Progression to Endometrial Carcinoma","volume":"23","author":"Sutter","year":"2004","journal-title":"Int. J. Gynecol. Pathol."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"1609906","DOI":"10.3389\/pore.2021.1609906","article-title":"The Advance and Correlation of KRAS Mutation with the Fertility-Preservation Treatment of Endometrial Cancer in the Background of Molecular Classification Application","volume":"27","author":"Yu","year":"2021","journal-title":"Pathol. Oncol. Res."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/s41389-021-00337-8","article-title":"Kras Activation in Endometrial Organoids Drives Cellular Transformation and Epithelial-Mesenchymal Transition","volume":"10","author":"Maru","year":"2021","journal-title":"Oncogenesis"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"e13137","DOI":"10.1111\/ecc.13137","article-title":"Molecular Biomarkers Predicting Early Development of Endometrial Carcinoma: A Pilot Study","volume":"28","author":"Lupini","year":"2019","journal-title":"Eur. J. Cancer Care"},{"key":"ref_137","first-page":"A337","article-title":"548 Prognostic Biomarkers for Atypical Endometrial Hyperplasia: A Mini Review","volume":"31","author":"Sideris","year":"2021","journal-title":"Int. J. Gynecol. Cancer"},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"e000152","DOI":"10.1136\/bmjmed-2022-000152","article-title":"Endometrial Cancer: Molecular Classification and Future Treatments","volume":"1","author":"Corr","year":"2022","journal-title":"BMJ Med."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1002\/ijgo.14969","article-title":"Molecular Subtypes of Endometrial Cancer: Implications for Adjuvant Treatment Strategies","volume":"164","author":"Yang","year":"2024","journal-title":"Int. J. Gynaecol. Obstet."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"e36","DOI":"10.3802\/jgo.2023.34.e36","article-title":"Levonorgestrel-Releasing Intrauterine System-Based Therapies for Early-Stage Endometrial Cancer: A Systematic Review and Meta-Analysis","volume":"34","author":"Wei","year":"2023","journal-title":"J. Gynecol. Oncol."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"6803","DOI":"10.2147\/CMAR.S188087","article-title":"Fertility-Preserving Treatment in Women with Early Endometrial Cancer: The Chinese Experience","volume":"10","author":"Wang","year":"2018","journal-title":"Cancer Manag. Res."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1634\/theoncologist.2013-0445","article-title":"Progestins in the Fertility-Sparing Treatment and Retreatment of Patients with Primary and Recurrent Endometrial Cancer","volume":"20","author":"Park","year":"2015","journal-title":"Oncologist"},{"key":"ref_143","first-page":"893","article-title":"Risk of Endometrial, Ovarian, and Breast Cancers in Women with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis","volume":"20","author":"Amiri","year":"2022","journal-title":"Int. J. Reprod. Biomed."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1177\/2042018810380215","article-title":"Role of Metformin in the Management of Polycystic Ovary Syndrome","volume":"1","author":"Lashen","year":"2010","journal-title":"Ther. Adv. Endocrinol. Metab."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.1093\/ejendo\/lvad098","article-title":"The Impact of Metformin with or without Lifestyle Modification versus Placebo on Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis of Randomized Controlled Trials","volume":"189","author":"Melin","year":"2023","journal-title":"Eur. J. Endocrinol."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"e49","DOI":"10.3802\/jgo.2019.30.e49","article-title":"Combined Estrogen-Progestin Pill Is a Safe and Effective Option for Endometrial Hyperplasia without Atypia: A Three-Year Single Center Experience","volume":"30","author":"Wang","year":"2019","journal-title":"J. Gynecol. Oncol."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"hoac057","DOI":"10.1093\/hropen\/hoac057","article-title":"ESGO\/ESHRE\/ESGE Guidelines for the Fertility-Sparing Treatment of Patients with Endometrial Carcinoma","volume":"2023","author":"Rodolakis","year":"2023","journal-title":"Hum. Reprod. Open"},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"kz029","DOI":"10.1093\/jncics\/pkz029","article-title":"Postmenopausal Androgen Metabolism and Endometrial Cancer Risk in the Women\u2019s Health Initiative Observational Study","volume":"3","author":"Michels","year":"2019","journal-title":"JNCI Cancer Spectr."},{"key":"ref_149","doi-asserted-by":"crossref","unstructured":"Liang, Y., Jiao, H., Qu, L., and Liu, H. (2021). Association between Hormone Replacement Therapy and Development of Endometrial Cancer: Results from a Prospective US Cohort Study. Front. Med., 8.","DOI":"10.3389\/fmed.2021.802959"},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"32","DOI":"10.4103\/gmit.gmit_44_22","article-title":"Laparoscopic Surgery for Atypical Endometrial Hyperplasia with Awareness Regarding the Possibility of Endometrial Cancer","volume":"12","author":"Kamii","year":"2023","journal-title":"Gynecol. Minim. Invasive Ther."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"470","DOI":"10.3109\/13697137.2014.991302","article-title":"The Levonorgestrel-Releasing Intrauterine System for Endometrial Protection during Estrogen Replacement Therapy: A Clinical Review","volume":"18","author":"Depypere","year":"2015","journal-title":"Climacteric"},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1097\/AOG.0b013e31826bb121","article-title":"Society of Gynecologic Oncology Clinical Practice Committee Management of Endometrial Precancers","volume":"120","author":"Trimble","year":"2012","journal-title":"Obstet. Gynecol."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"103.e1","DOI":"10.1016\/j.ajog.2019.12.273","article-title":"Progestin Therapy for Obese Women with Complex Atypical Hyperplasia: Levonorgestrel-Releasing Intrauterine Device vs Systemic Therapy","volume":"223","author":"Mandelbaum","year":"2020","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_154","doi-asserted-by":"crossref","unstructured":"Gallo, A., Catena, U., Saccone, G., and Di Spiezio Sardo, A. (2021). Conservative Surgery in Endometrial Cancer. J. Clin. Med. Res., 11.","DOI":"10.3390\/jcm11010183"}],"container-title":["Diagnostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-4418\/14\/22\/2471\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T16:26:39Z","timestamp":1760113599000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-4418\/14\/22\/2471"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,5]]},"references-count":154,"journal-issue":{"issue":"22","published-online":{"date-parts":[[2024,11]]}},"alternative-id":["diagnostics14222471"],"URL":"https:\/\/doi.org\/10.3390\/diagnostics14222471","relation":{},"ISSN":["2075-4418"],"issn-type":[{"value":"2075-4418","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,5]]}}}